Articles
-
2 months ago |
finanzen.net | Victoria Mitchell |finanzen.net Redaktion
This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences.
-
2 months ago |
finanzen.net | Victoria Mitchell |finanzen.net Redaktion
This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences.
-
Jan 21, 2025 |
marketscreener.com | Victoria Mitchell
Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces it will hold an Extraordinary General Meeting of Shareholders (EGM) on March 4, 2025, at 14:00 CET. The Notice to Convene, Explanatory Notes, Voting information, meeting documents and Form of Proxy can be found on the Company’s website under Investors/Shareholder Meetings.
-
Jan 21, 2025 |
tradingview.com | Victoria Mitchell
Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive OfficerLeiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Board of Directors has nominated Fabrice Chouraqui to become Pharming’s new Executive Director and Chief Executive Officer, succeeding Sijmen de Vries.
-
Jan 21, 2025 |
menafn.com | Victoria Mitchell
Pharming Group To Convene Extraordinary General Meeting Of Shareholders 1/21/2025 12:16:15 PM (MENAFN- GlobeNewsWire - Nasdaq) Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or“the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces it will hold an Extraordinary General Meeting of shareholders (EGM) on March 4, 2025, at 14:00 CET.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 1K
- DMs Open
- No
RT @MediaMorrison: Well done to @CraigWRitchie our Outstanding Young Communicator - Hamp Hamilton Award winner #PRideSC @CIPR_Scotland
RT @LPGA: A historic week at a historic golf club. 🏆 Earlier this week, @thesophiagolf and her caddie @thebritneyham took a tour of the Mu…
RT @Women_and_Golf: Lindsey Garden, a member of The Honourable Company of Edinburgh Golfers, is a playing marker for Lydia Hall today at th…